FDA Clears Luminex xTAG Gastrointestinal Panel on MagPix Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex said today that it has received clearance from the US Food and Drug Administration for its MagPix instrument and xTAG Gastrointestinal Pathogen Panel, or GPP.

The xTAG GPP assay is the first clinical assay to be cleared in the US for the MagPix instrument. It also is the first FDA-cleared test that can simultaneously detect 11 common viral, bacterial, and parasitic causes of infectious gastroenteritis from a single stool sample, Luminex said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.